| abstract |
The present invention relates to a process for the preparation of Quillaja saponaria molina ( Quillaja) selected from sterol and quilarazanic acid and quillaja saponin saponaria Molina ), and the nanoparticles do not contain phospholipids. It also relates to compositions comprising said nanoparticles and, more particularly, to adjuvants in vaccines, as carriers for amphipathic or hydrophobic molecules and their use as cancer treatment agents. The present invention also relates to a method for producing the phospholipid-free nanoparticles, a method for treating cancer, and a method for evaluating applicability of the cancer treatment method. |